(MedPage Today) — Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with obesity, President Trump announced on Thursday.
As part of a new deal with the White House, doses of…
Source link : https://www.medpagetoday.com/publichealthpolicy/medicare/118344
Author :
Publish date : 2025-11-06 17:28:00
Copyright for syndicated content belongs to the linked Source.
